Horizon Blue Cross and Blue Shield of New Jersey policies, page 14

Search Horizon Blue Cross and Blue Shield of New Jersey's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

834 public policies Substrate tracks for Horizon Blue Cross and Blue Shield of New Jersey, by title.

Horizon Blue Cross and Blue Shield of New Jersey policies
PolicyDetailsCodesSource
Radiation Therapy for Cervical CancerCommercial—Original policy ↗
Radiation Therapy for Endometrial CancerCommercial—Original policy ↗
Radiation Therapy for Esophageal CancerCommercial—Original policy ↗
Radiation Therapy for Gastric CancerCommercial—Original policy ↗
Radiation Therapy for Head and Neck CancerCommercial—Original policy ↗
Radiation Therapy for Hepatobiliary CancerCommercial—Original policy ↗
Radiation Therapy for Hodgkin LymphomaCommercial—Original policy ↗
Radiation Therapy for Kidney and Adrenal CancerCommercial—Original policy ↗
Radiation Therapy for Multiple Myeloma and Solitary PlasmacytomasCommercial1Original policy ↗
Radiation Therapy for Non-Hodgkin's LymphomaCommercial—Original policy ↗
Radiation Therapy for Non-Malignant DiseaseCommercial—Original policy ↗
Radiation Therapy for Non-Small-Cell Lung CancerCommercial, Medicaid—Original policy ↗
Radiation Therapy for OligometastasesCommercial—Original policy ↗
Radiation Therapy for Pancreatic CancerCommercial—Original policy ↗
Radiation Therapy for Primary Craniospinal Tumors and Neurologic ConditionsCommercial—Original policy ↗
Radiation Therapy for Prostate CancerCommercial, Medicaid—Original policy ↗
Radiation Therapy for Rectal CancerCommercial—Original policy ↗
Radiation Therapy for Skin Cancer - Basal Cell and Squamous CellCommercial, Medicaid—Original policy ↗
Radiation Therapy for Skin Cancer - MelanomaCommercial, Medicaid—Original policy ↗
Radiation Therapy for Small Cell Lung CancerCommercial, Medicaid—Original policy ↗
Radiation Therapy for Soft Tissue SarcomasCommercial—Original policy ↗
Radiation Therapy for Testicular CancerCommercial—Original policy ↗
Radiation Therapy for Thymoma and Thymic CancerCommercial—Original policy ↗
Radiation Therapy for Urethral Cancer and Upper Genitourinary Tract TumorsCommercial—Original policy ↗
Radiation Therapy for Vulvar CancerCommercial—Original policy ↗
Radiation Treatment with Azedra (Iobenguane I-131)Commercial—Original policy ↗
Radiation Treatment with Lutathera (Lutetium; Lu 177 dotatate)Commercial—Original policy ↗
Radioactive Seed Localization of Nonpalpable Breast LesionsEffective Jul 8, 2019 · Commercial6Original policy ↗
Radioembolization for Primary and Metastatic Tumors of the LiverCommercial, Medicaid—Original policy ↗
Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver TumorsCommercial—Original policy ↗
Radiofrequency Ablation of Primary or Metastatic Liver TumorsCommercial, Medicaid—Original policy ↗
Radiofrequency Ablation of the Renal Sympathetic Nerves as a Treatment for Resistant HypertensionEffective Jul 8, 2019 · Commercial—Original policy ↗
Radiofrequency Coblation Tenotomy for Musculoskeletal ConditionsCommercial, Medicaid—Original policy ↗
Radiofrequency Joint Ablation/DenervationCMM-208 · Commercial—Original policy ↗
Radioimmunotherapy with Zevalin®Commercial—Original policy ↗
Radiology, Preliminary and Double ReadsEffective Jan 1, 2013 · Commercial, Medicaid—Original policy ↗
RadiopharmaceuticalsCommercial—Original policy ↗
Recombinant and Autologous Platelet-Derived Growth Factors as a Treatment of Wound Healing and Other Non-Orthopedic ConditionsCommercial, Medicaid—Original policy ↗
Recombinant Interleukin-2 (IL-2)Commercial—Original policy ↗
Reduction MammaplastyCommercial, Medicaid—Original policy ↗
Refractive Keratoplasty ProceduresCommercial, Medicaid2Original policy ↗
Regional Sympathetic BlocksCMM-209 · Commercial, Medicaid2Original policy ↗
Reimbursement / PaymentCommercial—Original policy ↗
Removal of Benign Skin LesionsCommercial, Medicaid—Original policy ↗
Removal of Impacted Cerumen Requiring InstrumentationEffective Nov 16, 2015 · Commercial, Medicaid3Original policy ↗
Respiratory Syncytial Virus Infection ProphylaxisCommercial—Original policy ↗
Responsive Neurostimulation for the Treatment of Refractory Partial EpilepsyCommercial, Medicaid—Original policy ↗
Retinal ProsthesisCommercial1Original policy ↗
Retinoids, TopicalCommercial—Original policy ↗
Rhinomanometry and Acoustic/Optical RhinometryCommercial, Medicaid—Original policy ↗

Back to Horizon Blue Cross and Blue Shield of New Jersey

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.